Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Wei Sheen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|June 28, 2014
Novel high-throughput screen identifies an HIV-1 reverse transcriptase inhibitor with a unique mechanism of actionChih-Wei Sheen, Onur Alptürk, Nicolas Sluis-Cremer
Antimicrobial Agents and Chemotherapy|October 31, 2007
Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 Reverse transcriptase facilitates dual resistance to zidovudine and lamivudineShannon Zelina, Chih-Wei Sheen, Jessica Radzio, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitorsNicolas Sluis-Cremer, Chih-Wei Sheen, Shannon Zelina, et al.
The Biochemical Journal|February 9, 2007
Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RTDwight V Nissley, Jessica Radzio, Zandrea Ambrose, et al.
Journal of Virology|February 6, 2009
The human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogsZandrea Ambrose, Brian D Herman, Chih-Wei Sheen, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 12, 2008
Novel N-3 substituted TSAO-T derivatives: synthesis and anti-HIV-evaluationMaría-Cruz Bonache, Ernesto Quesada, Chih-Wei Sheen, et al.
Plos Medicine|December 7, 2007
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistanceSoo-Huey Yap, Chih-Wei Sheen, Jonathan Fahey, et al.
AIDS (London, England)|November 14, 2008
Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiencyP Richard Harrigan, Chih-Wei Sheen, Vikram S Gill, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|June 28, 2014
Novel high-throughput screen identifies an HIV-1 reverse transcriptase inhibitor with a unique mechanism of actionChih-Wei Sheen, Onur Alptürk, Nicolas Sluis-Cremer
Antimicrobial Agents and Chemotherapy|October 31, 2007
Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 Reverse transcriptase facilitates dual resistance to zidovudine and lamivudineShannon Zelina, Chih-Wei Sheen, Jessica Radzio, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitorsNicolas Sluis-Cremer, Chih-Wei Sheen, Shannon Zelina, et al.
The Biochemical Journal|February 9, 2007
Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RTDwight V Nissley, Jessica Radzio, Zandrea Ambrose, et al.
Journal of Virology|February 6, 2009
The human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogsZandrea Ambrose, Brian D Herman, Chih-Wei Sheen, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 12, 2008
Novel N-3 substituted TSAO-T derivatives: synthesis and anti-HIV-evaluationMaría-Cruz Bonache, Ernesto Quesada, Chih-Wei Sheen, et al.
Plos Medicine|December 7, 2007
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistanceSoo-Huey Yap, Chih-Wei Sheen, Jonathan Fahey, et al.
AIDS (London, England)|November 14, 2008
Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiencyP Richard Harrigan, Chih-Wei Sheen, Vikram S Gill, et al.
Pageof 1